Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis by Sharma, Neeraj, Evans, Taylor A, Pellicore, Matthew J, Davis, Emily, Aksit, Melis A, McCague, Allison F, Joynt, Anya T, Lu, Zhongzhu, Han, Sangwoo T, Anzmann, Arianna F, Lam, Anh-Thu N, Thaxton, Abigail, West, Natalie, Merlo, Christian, Gottschalk, Laura B, Raraigh, Karen S, Sosnay, Patrick R, Cotton, Calvin U, Cutting, Garry R

Get full text

Cardiolipin’s Remodeling Rules Revealed: The Role of the Cellular Lipidome by Sniezek, Olivia L., Anzmann, Arianna F., Claypool, Steven M., Vernon, Hilary J.

Get full text

Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome by Sniezek Carney, Olivia, Harris, Kodi W, Wohlfarter, Yvonne, Lee, Kyuna, Butschek, Grant, Anzmann, Arianna F, Hamacher-Brady, Anne, Keller, Markus A, Vernon, Hilary J

Get full text

Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis by Lam, Anh-Thu N, Aksit, Melis A, Vecchio-Pagan, Briana, Shelton, Celeste A, Osorio, Derek L, Anzmann, Arianna F, Goff, Loyal A, Whitcomb, David C, Blackman, Scott M, Cutting, Garry R

Get full text

Diverse mitochondrial abnormalities in a new cellular model of TAFFAZZIN deficiency are remediated by cardiolipin-interacting small molecules by Anzmann, Arianna F., Sniezek, Olivia L., Pado, Alexandra, Busa, Veronica, Vaz, Frédéric M., Kreimer, Simion D., DeVine, Lauren R., Cole, Robert N., Le, Anne, Kirsch, Brian J., Claypool, Steven M., Vernon, Hilary J.

Get full text